DUBLIN, January 18, 2016 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/n33bc6/global_crispr) has announced the addition of the "Global CRISPR Market 2015 - 2021" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The Global CRISPR Market is driven by high demand for plasmids, synthetic genes and high quality gene slicing techniques. Growing drug discovery, biotechnology and proteomics markets are also driving the market growth.
The market is expected to grow at a CAGR of 43% from 2015 to 2021. This is driven by the fact that CRISPR is a new technology which is simple, more efficient and cost effective as compared to its peers. High adoption both in biotech and pharma industry along with high level of research is also responsible for high growth rate.
The market for CRISPR technology is niche. The number of companies are still very less and most of the companies are start-ups which are going through rounds of funding.
Most of the companies are relying on the disruptive nature of the technology. CRISPR has the capability to open new markets for gene surgery and genetically modified organisms. However, there are major concerns from the scientific community regarding the misuse of such technology in human cloning. Geographically North America leads the market race followed by Europe and Asia Pacific.
Companies Mentioned:
Key Topics Covered:
1. Executive Summary
2. Market Overview
3. Sector Analysis
4. Market Determinants
5. Market Segmentation
6. Geographical Analysis
7. Company Profiling
For more information visit http://www.researchandmarkets.com/research/n33bc6/global_crispr
About Research and Markets:
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Laura Wood
+353-1-481-1716
press@researchandmarkets.net
Share this article